,
your personalized virtual assistant to find clinical trials. Go head, 
Glenn Bubley, MD
Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 7
- CONDITIONS5
- INTERVENTIONS19
- SINCE2008
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
June 2009 - December 2012
Ketoconazole Hydrocortisone Dutasteride and Lapatanib (KHAD-L) in Prostate Cancer
August 2009 - August 2011
Avastin Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy
April 2008 - April 2011
Metformin in Castration-Resistant Prostate Cancer
September 2010 - September 2012
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
December 2008 - December 2010
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
October 2008 - August 2011
Neoadjuvant Abiraterone Acetate Plus Leuprolide Acetate in Men With Localized High Risk Prostate Cancer
September 2009 - December 2010
Prostatic Neoplasms
Neoplasms
Carcinoma
Recurrence
Carcinoma, Transitional Cell
Bevacizumab
Cisplatin
Docetaxel
Methotrexate
Avastin
Dutasteride
Bicalutamide
Leuprolide Acetate
Hydrocortisone
Panobinostat
Pegfilgrastim
Metformin
Ketoconazole
Doxorubicin
Vinblastine
Lapatanib
Lupron Or Zoladex
Androgen Deprivation Therapy
Abiraterone Acetate Plus Leuprolide Acetate Plus Prednisone
